MLL Legal advised the founders and shareholders of Distona, a Swiss distributor of speciality and basic raw materials, on the company’s sale to the Belgium-based distributor of food ingredients and specialty chemicals Azelis Group.
Unigestion completed the sale of the entire share capital of Unigestion Private Equity Holding – the head holding of Unigestion’s private equity business – to the Canadian alternative asset management group Sagard. In connection with the
Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line
Swedish trading company Bufab Group completed the acquisition of Novia Group – a German-based provider of global sourcing solutions and engineering services operating across Germany, Switzerland, China, and Vietnam – from the German investment company Family Trust.
Borel & Barbey advised Marteau & Co, a newly-established online Swiss auctioneer and platform, on its debut and maiden online auction – planned to go live from Wednesday 15 October until Thursday 23 October 2025. The company Marteau &
Homburger advised Idorsia on a placement of 16.4 m shares through an accelerated bookbuilding process, raising gross proceeds of CHF 65.6 m in aggregate, at an offer price of CHF 4.00 per offered share. In connection with the
Welcome to Signed Sealed Weekend,This week’s newsroom activity saw multiple funding round, let’s go through some of them. Kellerhals Carrard advised FenX – a Swiss cleantech company and ETH spin-off transforming waste into
Niederer Kraft Frey (NKF) advised SoftBank Group Corp in its agreement with electrification and automation specialist ABB to acquire the latter’s robotics business, valued at USD 5.375 billion. Closing is planned for mid-to-late 2026, subject to
Bloch Avocats advised QARAlink, a Denges-based medtech startup operating an AI-supported regulatory intelligence platform for MedTech and HealthTech companies, throughout a USD 936,000 pre-seed funding round , valuing the company at USD 5.6 million. The Bloch Avocats team
Lenz & Staehelin advised SQ Innovation, a life-science company specialised in the treatment of worsening heart failure, throughout closing of its Series B financing round. Newly-appointed member of the company’s supervisory board Marco van
